Search results

View (previous 20 | ) (20 | 50 | 100 | 250 | 500)
  • Thumbnail for Telaprevir
    Telaprevir (category NS3/4A protease inhibitors)
    inhibitors. Specifically, telaprevir inhibits the hepatitis C viral enzyme NS3/4A serine protease. Telaprevir is only indicated for use against hepatitis...
    12 KB (1,128 words) - 06:18, 17 September 2023
  • Thumbnail for Hepatitis C virus nonstructural protein 4A
    protein found in the hepatitis C virus. It acts as a cofactor for the enzyme NS3. Beld M, Penning M, van Putten M, et al. (October 1998). "Hepatitis C virus...
    753 bytes (76 words) - 04:20, 16 July 2023
  • Thumbnail for Voxilaprevir
    Voxilaprevir (category NS3/4A protease inhibitors)
    Voxilaprevir is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor (by Gilead) that is used in combination with sofosbuvir and...
    4 KB (119 words) - 16:37, 28 January 2023
  • Thumbnail for Hepatitis C virus nonstructural protein 3
    Nonstructural protein 3 (NS3), also known as p-70, is a viral nonstructural protein that is 70 kDa cleavage product of the hepatitis C virus polyprotein...
    2 KB (250 words) - 04:26, 16 July 2023
  • Thumbnail for Ciluprevir
    Ciluprevir (category NS3/4A protease inhibitors)
    first-in-class NS3/4A protease inhibitor to enter clinical development and tested in human. Ciluprevir is a potent competitive reversible inhibitor of NS3/4A protease...
    4 KB (221 words) - 23:58, 3 April 2023
  • Sofosbuvir/velpatasvir/voxilaprevir (category NS3/4A protease inhibitors)
    Sofosbuvir NS5B RNA polymerase inhibitor Velpatasvir NS5A inhibitor Voxilaprevir NS3/4A protease inhibitor Clinical data Trade names Vosevi AHFS/Drugs.com Monograph...
    6 KB (161 words) - 03:41, 14 April 2024
  • Thumbnail for Asunaprevir
    Asunaprevir (category NS3/4A protease inhibitors)
    Asunaprevir is an inhibitor of the hepatitis C virus enzyme serine protease NS3. Asunaprevir is being tested in combination with pegylated interferon and...
    7 KB (271 words) - 05:20, 7 April 2024
  • Thumbnail for Danoprevir
    Danoprevir (category NS3/4A protease inhibitors)
    an orally available 15-membered macrocyclic peptidomimetic inhibitor of NS3/4A HCV protease. It contains acylsulfonamide, fluoroisoindole and tert-butyl...
    7 KB (487 words) - 04:54, 20 October 2023
  • Thumbnail for Vaniprevir
    Vaniprevir (category NS3/4A protease inhibitors)
    Vaniprevir (MK-7009) is a macrocyclic hepatitis C virus (HCV) NS3/4A protease inhibitor, developed by Merck & Co., which is currently in clinical testing...
    3 KB (145 words) - 20:58, 1 December 2023
  • Thumbnail for Sovaprevir
    Sovaprevir (category NS3/4A protease inhibitors)
    virus. It is under development by Achillion Pharmaceuticals. It acts as a NS3/4A inhibitor. Sovaprevir received fast track status from the U.S. Food and...
    3 KB (91 words) - 23:50, 11 November 2023
  • Thumbnail for Glecaprevir/pibrentasvir
    Glecaprevir/pibrentasvir (category NS3/4A protease inhibitors)
    moderate to severe liver disease. Glecaprevir works by blocking the protein NS3/4A protease, while pibrentasvir works by blocking NS5A. The combination was...
    10 KB (870 words) - 03:38, 14 April 2024
  • Thumbnail for Pestivirus
    viral RNAs ability to replicate, NS3 has little impact on the assembly of the virus. Only in the NS3/NS4A complex can the NS3 protease reach peak activity...
    32 KB (3,927 words) - 19:21, 19 April 2024
  • Thumbnail for Bukit Gombak MRT station
     NS3  Bukit Gombak 武吉甘柏 புக்கிட் கோம்பாக் Mass Rapid Transit (MRT) station Platform B of Bukit Gombak MRT station General information Location 802 Bukit...
    5 KB (259 words) - 20:59, 17 December 2023
  • Thumbnail for Narlaprevir
    Narlaprevir (category NS3/4A protease inhibitors)
    Narlaprevir (trade name Arlansa, codenamed SCH 900518), is an inhibitor of NS3/4A serine protease, intended for the treatment of chronic hepatitis C caused...
    13 KB (1,100 words) - 23:50, 9 February 2024
  • Thumbnail for Paritaprevir
    Paritaprevir (category NS3/4A protease inhibitors)
    Paritaprevir (previously known as ABT-450) is an acylsulfonamide inhibitor of the NS3-4A serine protease manufactured by Abbott Laboratories that shows promising...
    6 KB (352 words) - 19:28, 20 December 2023
  • Pestivirus NS3 polyprotein peptidase (EC 3.4.21.113, border disease virus NS3 endopeptidase, BDV NS3 endopeptidase, bovine viral diarrhea virus NS3 endopeptidase...
    3 KB (279 words) - 15:20, 26 August 2023
  • Thumbnail for Grazoprevir
    Grazoprevir (category NS3/4A protease inhibitors)
    is a second generation hepatitis C virus protease inhibitor acting at the NS3/4A protease targets. It has good activity against a range of HCV genotype...
    9 KB (636 words) - 08:37, 2 June 2023
  • Thumbnail for Faldaprevir
    Faldaprevir (category NS3/4A protease inhibitors)
    Faldaprevir was an experimental drug for the treatment of hepatitis C (HCV). It was being developed by Boehringer-Ingelheim and reached Phase III clinical...
    4 KB (192 words) - 20:12, 3 January 2024
  • Elbasvir/grazoprevir (category NS3/4A protease inhibitors)
    elbasvir (an inhibitor of hepatitis C virus's NS5A protein) and grazoprevir (an NS3/4A inhibitor). It is used to treat chronic hepatitis C virus (HCV) genotypes...
    20 KB (1,817 words) - 05:19, 7 April 2024
  • Thumbnail for Hepatitis C virus nonstructural protein 2
    nonstructural protein 3 (NS3). The NS2-3 autoprotease acts by making a single cleavage between the junction of NS2 and NS3. While the NS2 protein itself...
    9 KB (1,152 words) - 00:49, 3 December 2023
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)